Literature DB >> 24130250

Hypercalcemia in the Intensive Care Unit: A Review of Pathophysiology, Diagnosis, and Modern Therapy.

Joshua D Maier1, Steven N Levine2.   

Abstract

Hypercalcemia may be seen in a variety of clinical settings and often requires intensive management when serum calcium levels are dramatically elevated. All of the many etiologies of mild hypercalcemia can lead to severe hypercalcemia. Knowledge of the physiologic mechanisms involved in maintaining normocalcemia and basic pathophysiology is essential for making a timely diagnosis and hence prompt institution of etiology-specific therapy. The development of new medications and critical reviews of traditional therapies have changed the treatment paradigm for severe hypercalcemia, calling for a more limited role for aggressive isotonic fluid administration and furosemide and an expanded role for calcitonin and the bisphosphonates. Experimental therapies such as denosumab show promise.
© The Author(s) 2013.

Entities:  

Keywords:  hypercalcemia; hyperparathyroidism; malignancy-associated hypercalcemia; parathyroid hormone–related protein

Mesh:

Substances:

Year:  2013        PMID: 24130250     DOI: 10.1177/0885066613507530

Source DB:  PubMed          Journal:  J Intensive Care Med        ISSN: 0885-0666            Impact factor:   3.510


  13 in total

1.  Exploring the prognostic significance of preoperative high normocalcemia in epithelial ovarian carcinoma.

Authors:  Hyun-Woong Cho; Yung-Taek Ouh; Jin Hwa Hong; Jae Kwan Lee
Journal:  Arch Gynecol Obstet       Date:  2020-10-19       Impact factor: 2.344

2.  Long-term hypervitaminosis D-induced hypercalcaemia treated with glucocorticoids and bisphosphonates.

Authors:  Chase C Houghton; Susie Q Lew
Journal:  BMJ Case Rep       Date:  2020-04-29

3.  Point of care blood gases with electrolytes and lactates in adult emergencies.

Authors:  Dheeraj Kapoor; Meghana Srivastava; Pritam Singh
Journal:  Int J Crit Illn Inj Sci       Date:  2014-07

4.  Epidemiology, clinical features, and management of severe hypercalcemia in critically ill patients.

Authors:  Cyril Mousseaux; Axelle Dupont; Cédric Rafat; Kenneth Ekpe; Etienne Ghrenassia; Lionel Kerhuel; Fanny Ardisson; Eric Mariotte; Virginie Lemiale; Benoît Schlemmer; Elie Azoulay; Lara Zafrani
Journal:  Ann Intensive Care       Date:  2019-11-27       Impact factor: 6.925

5.  Regional citrate anticoagulation versus low molecular weight heparin anticoagulation for continuous venovenous hemofiltration in patients with severe hypercalcemia: a retrospective cohort study.

Authors:  Yan Yu; Ming Bai; Zhang Wei; Lijuan Zhao; Yangping Li; Feng Ma; Shiren Sun
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

6.  An unusual case of severe hypercalcemia: as dehydrated as a bone.

Authors:  Roshan Acharya; Dylan M Winters; Cameron Rowe; Nathan Buckley; Smita Kafle; Bhaskar Chhetri
Journal:  J Community Hosp Intern Med Perspect       Date:  2021-01-26

7.  Case Report: Acute Kidney Injury Due to Chronic Milk-Alkali Syndrome in a Patient With Colon Cancer.

Authors:  Hyo Jin Lee; Seokho Yoon; Bong-Hoi Choi; Seunghye Lee; Sehyun Jung; Ha Nee Jang; Se-Ho Chang; Hyun-Jung Kim
Journal:  Front Med (Lausanne)       Date:  2022-02-04

8.  Prevalence of hypercalcemia among cancer patients in the United States.

Authors:  Victor M Gastanaga; Lee S Schwartzberg; Rajul K Jain; Melissa Pirolli; David Quach; Jane M Quigley; George Mu; W Scott Stryker; Alexander Liede
Journal:  Cancer Med       Date:  2016-06-05       Impact factor: 4.452

9.  Hypercalcemia-Induced Hypokalemic Metabolic Alkalosis in a Multiple Myeloma Patient: The Risk of Furosemide Use.

Authors:  Ira W Reiser; Slamat Ali; Vladimir Gotlieb; Samuel Spitalewitz
Journal:  Case Rep Oncol       Date:  2015-09-18

10.  Successful Treatment for Hypercalcemia due to Cosecretion of Parathyroid Hormone-Related Protein and 1,25-Dihydroxyvitamin D3 in Non-Small-Cell Lung Cancer: A Case Report and Literature Review.

Authors:  Takunori Ogawa; Jun Miyata; Koichi Fukunaga; Akihiko Kawana; Takashi Inoue
Journal:  Case Rep Pulmonol       Date:  2020-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.